Eleva Capital SAS
13F Reported Value
ⓘ$343.4M
Holdings
24
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Eleva Capital SAS disclosed 24 positions worth $343.4M in its Form 13F-HR for Q2 2026, led by $CRH (CRH PUBLIC LTD CO) at 81.3% of the equity portfolio, followed by $AS and $NVDA. The portfolio is most concentrated in Materials (81.3% of disclosed assets). All figures are sourced directly from Eleva Capital SAS’s Form 13F-HR filing with the SEC under CIK 2054496.
AI Fund Analysis
StableSector Allocation
13fpro.ai/research/fund/eleva-capital-sas-2054496
AUM History
13fpro.ai/research/fund/eleva-capital-sas-2054496
Top Equity Holdings by Value
13fpro.ai/research/fund/eleva-capital-sas-2054496
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- —
Quality
$279.1M2,654,974 sh - 63.9#563
Quality
$9.8M298,802 sh - 85.9#5
Quality
$9.1M52,002 sh - 78.6
Quality
$8.4M87,190 sh - 78.1
Quality
$8.0M27,967 sh - $6.5M21,411 sh
- 81.8
Quality
$5.8M46,957 sh - 68.4
Quality
$3.4M16,155 sh - 68.8
Quality
$3.0M14,347 sh - 81.9
Quality
$2.2M31,625 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| — | $279.1M | 2,654,974 | |
| 63.9#563 | $9.8M | 298,802 | |
| 85.9#5 | $9.1M | 52,002 | |
| 78.6 | $8.4M | 87,190 | |
| 78.1 | $8.0M | 27,967 | |
| — | $6.5M | 21,411 | |
| 81.8 | $5.8M | 46,957 | |
| 68.4 | $3.4M | 16,155 | |
| 68.8 | $3.0M | 14,347 | |
| 81.9 | $2.2M | 31,625 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Eleva Capital SAS's 24 positions.
Showing top 10 of 24 holdings.
Sector Allocation
Materials
$279.2M
Technology
$29.4M
Consumer Discretionary
$14.9M
Communication Services
$12.7M
Healthcare
$4.9M
Financials
$2.2M
Industrials
$111,331
Full Holdings — Eleva Capital SAS (Q2 2026)
All 24 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | CRH PUBLIC LTD CO | $279.1M | 81.3% | +0% | — | |
| 2 | Amer Sports, Inc. | $9.8M | 2.9% | +0% | 63.9 | |
| 3 | NVIDIA CORP | $9.1M | 2.6% | +0% | 85.9 | |
| 4 | NETFLIX INC | $8.4M | 2.4% | +0% | 78.6 | |
| 5 | Alphabet Inc. | $8.0M | 2.3% | +0% | 78.1 | |
| 6 | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $6.5M | 1.9% | +0% | — | |
| 7 | Arista Networks, Inc. | $5.8M | 1.7% | +0% | 81.8 | |
| 8 | AMAZON COM INC | $3.4M | 1.0% | +0% | 68.4 | |
| 9 | T-Mobile US, Inc. | $3.0M | 0.9% | +0% | 68.8 | |
| 10 | Robinhood Markets, Inc. | $2.2M | 0.6% | +0% | 81.9 | |
| 11 | On Holding AG | $1.7M | 0.5% | +0% | 53 | |
| 12 | BOSTON SCIENTIFIC CORP | $1.7M | 0.5% | +0% | 77.3 | |
| 13 | Spotify Technology S.A. | $1.3M | 0.4% | +0% | — | |
| 14 | NewAmsterdam Pharma Co N.V. | $823,329 | 0.2% | +0% | — | |
| 15 | CG Oncology, Inc. | $561,000 | 0.2% | +0% | 26.7 | |
| 16 | Esperion Therapeutics, Inc. | $501,549 | 0.1% | +0% | 46.2 | |
| 17 | Mineralys Therapeutics, Inc. | $462,724 | 0.1% | +0% | — | |
| 18 | FENNEC PHARMACEUTICALS INC. | $327,389 | 0.1% | +0% | 35.6 | |
| 19 | Disc Medicine, Inc. | $327,053 | 0.1% | +0% | — | |
| 20 | Viridian Therapeutics, Inc.\DE | $139,385 | 0.0% | +0% | 27 | |
| 21 | FREEPORT-MCMORAN INC | $132,725 | 0.0% | +0% | 61.7 | |
| 22 | Archer Aviation Inc. | $111,331 | 0.0% | +0% | 24.1 | |
| 23 | Edgewise Therapeutics, Inc. | $54,990 | 0.0% | +0% | — | |
| 24 | Aquestive Therapeutics, Inc. | $11,288 | 0.0% | +0% | 14.5 |
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Eleva Capital SAS including:
Track Eleva Capital SAS's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Eleva Capital SAS and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Eleva Capital SAS
13F Pro is an AI hedge fund tracker and stock research platform. For Eleva Capital SAS (SEC CIK: 2054496), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Eleva Capital SAS's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.